Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

Protective strategies against perinatal brain injury represent a major challenge for modern neonatology. Erythropoietin (Epo) enhances endogenous mechanisms of repair and angiogenesis. In order to analyse the newest evidence on the role of Epo in prematurity, hypoxic ischemic encephalopathy (HIE) an...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Serafina Perrone, Chiara Lembo, Federica Gironi, Chiara Petrolini, Tiziana Catalucci, Giulia Corbo, Giuseppe Buonocore, Eloisa Gitto, Susanna Maria Roberta Esposito
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	MDPI AG 2022-03-01
Serie:	Antioxidants
Ämnen:	erythropoietin newborn neuroprotection preterm Hypoxic Ischemic Encephalopathy perinatal stroke
Länkar:	https://www.mdpi.com/2076-3921/11/4/652
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!